UnitedHealth Group Incorporated (UNH)
Buying UnitedHealth Before Q4 Earnings? Cost Pressures a Red Flag
UNH heads into Q4 earnings with revenue growth intact, but earnings set to plunge, as rising medical costs and a higher MCR pressure margin.
Countdown to UnitedHealth (UNH) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for UnitedHealth (UNH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
UnitedHealth Group (UNH) Outperforms Broader Market: What You Need to Know
In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $347.75, denoting a +2.75% move from the preceding trading day.
UNH vs. MOH: Which Insurer Can Better Navigate Current Volatility?
UnitedHealth's scale and Optum diversification give it an edge over Molina as health insurers face policy-driven volatility and rising cost pressures.
Eyes Back On UnitedHealth As First Health Insurer To Report Earnings
All eyes are on UnitedHealth Group for signs the company – and the health insurance industry as a whole – are getting a handle on rising costs that have dogged the nation's giant health insurers for the last two years.
UnitedHealth Group (UNH) Surpasses Market Returns: Some Facts Worth Knowing
The latest trading day saw UnitedHealth Group (UNH) settling at $338.96, representing a +1.19% change from its previous close.
UNH Stock vs. CVS
UnitedHealth‘s stock has significantly lagged behind competitors like CVS and Centene over the previous year. A detailed examination indicates strong profitability, with an LTM Operating Margin of 6%, combined with a moderate valuation, as reflected by a PE of 17.2 in contrast to CVS's 218.3.
Does UnitedHealth's MA Pilot Signal a New Rural Support Model?
UNH's six-month pilot speeds MA payments by ~50%, cutting cycles under 15 days to ease cash-flow strain for rural hospitals.
Is UnitedHealth (UNH) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Here is What to Know Beyond Why UnitedHealth Group Incorporated (UNH) is a Trending Stock
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
UnitedHealth: Inflection Confirmation Imminent
UnitedHealth Group Incorporated navigated a turbulent 2025 with management changes, mispriced costs, and a surging medical cost ratio, but revenue growth remained robust. We expect 2026 EPS guidance in the high teens, signaling a double-digit rebound off 2025's $16.25–$16.50 floor, with confirmation of inflection imminent at the upcoming earnings. Dividend growth and a 2.8% yield provide income while awaiting margin recovery; buybacks are paused but likely to resume as cash flow improves.
UnitedHealth Could Re-Take Its All-Time High In 2026
Recently the U.S. Senate approved another round of Affordable Care Act (ACA) subsidy extensions. Trump said he "might" veto the subsidy extensions, but he did not conclusively say he would. UnitedHealth's stock got beaten down partially because the subsidies were expected to expire. The subsidies did in fact expire, but were re-instated and extended. Just recently, the company re-affirmed its full year earnings guidance for 2026, a number that implies significant growth over the trailing 12 month period.
